Kimberly-Clark to Acquire Kenvue in $48.7 Billion Consumer Staples Deal
TL;DR Summary
Kimberly-Clark is acquiring Kenvue, the maker of Tylenol, for $40 billion, creating a leading health and wellness company with over $32 billion in revenue, despite legal and market challenges related to Tylenol's safety concerns and recent financial struggles of Kenvue.
- Kimberly-Clark to Buy Tylenol Owner Kenvue in $40 Billion Deal Bloomberg
- Kimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giant CNBC
- Kimberly-Clark to buy Kenvue, maker of Tylenol, in $48 billion deal USA Today
- Tylenol’s parent company will combine with the maker of Huggies in a $48.7 billion mega-deal CNN
- Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal Yahoo Finance
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
92%
495 → 40 words
Want the full story? Read the original article
Read on Bloomberg